UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058600
Receipt number R000067004
Scientific Title A retrospective study to evaluate the tolerability of outpatient initiation of platinum-based combination therapy with carboplatin
Date of disclosure of the study information 2025/07/25
Last modified on 2025/07/25 18:23:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A retrospective study to evaluate the tolerability of outpatient initiation of platinum-based combination therapy with carboplatin

Acronym

A retrospective study on the safety of carboplatin-based chemotherapy initiation in outpatient settings

Scientific Title

A retrospective study to evaluate the tolerability of outpatient initiation of platinum-based combination therapy with carboplatin

Scientific Title:Acronym

A retrospective study on the safety of carboplatin-based chemotherapy initiation in outpatient settings

Region

Japan


Condition

Condition

Non-small cell lung cancer

Classification by specialty

Pneumology Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of the tolerability of outpatient initiation of first-line carboplatin-based combination therapy in patients with advanced or recurrent non-small cell lung cancer.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Completion rate of 4 chemotherapy courses

Key secondary outcomes

Unscheduled medical visit rate up to 4 cycles, Adverse events of grade 3 or higher, Progression-free survival, Overall survival, Dose reduction rate during 4 cycles of treatment


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Eligible cases are those who meet either (1) or (2) below and also meet (3).
(1) Patients with advanced or recurrent non-small cell lung cancer with a performance status (PS) of 0-1 who have started initial systemic chemotherapy with a regimen containing carboplatin.
(2) Patients with advanced or recurrent non-small cell lung cancer with a PS of 0-1 who have started initial systemic chemotherapy with a regimen containing carboplatin after molecular targeted drug therapy.
(3) Patients who started initial treatment between January 1, 2019 and December 31, 2022.

Key exclusion criteria

Patients who meet any of the following criteria will be excluded.
Those who have expressed refusal to participate in this study through a disclosure document.
Cases in which initial systemic chemotherapy was administered after unplanned emergency hospitalization.
Those treated with the Atezolizumab+Bevacizumab+Carboplatin+Paclitaxel (ABCP) regimen (In reality, it takes more than 5-6 hours to administer the drugs, making it difficult to administer the regimen in an outpatient chemotherapy room. Therefore, it is not possible to compare the outpatient and inpatient groups.)

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Takuji
Middle name
Last name Suzuki

Organization

Chiba University Hospital

Division name

Department of Respiratory medicine

Zip code

260-8677

Address

1-8-1, Inohana, Chuo-ku, Chiba city, Chiba

TEL

043-222-7171

Email

suzutaku@chiba-u.jp


Public contact

Name of contact person

1st name Fujihiro
Middle name
Last name Kure

Organization

Chiba University Hospital

Division name

Department of Respiratory medicine

Zip code

260-8677

Address

1-8-1, Inohana, Chuo-ku, Chiba city, Chiba

TEL

043-222-7171

Homepage URL


Email

23fd0146@student.gs.chiba-u.jp


Sponsor or person

Institute

Chiba University Hospital

Institute

Department

Personal name



Funding Source

Organization

Chiba University Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Funabashi Municipal Medical Center, Chiba Cancer Center Research Institute

Name of secondary funder(s)

None


IRB Contact (For public release)

Organization

The Research Ethics Committees of Graduate School of Medicine, Chiba University

Address

1-8-1, Inohana, Chuo-ku, Chiba city, Chiba

Tel

043-222-7171

Email

inohana-rinri@chiba-u.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 07 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

344

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2024 Year 09 Month 26 Day

Date of IRB

2024 Year 09 Month 26 Day

Anticipated trial start date

2024 Year 09 Month 26 Day

Last follow-up date

2025 Year 03 Month 30 Day

Date of closure to data entry

2025 Year 03 Month 30 Day

Date trial data considered complete

2025 Year 03 Month 30 Day

Date analysis concluded



Other

Other related information

None


Management information

Registered date

2025 Year 07 Month 25 Day

Last modified on

2025 Year 07 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067004